Development of validated HPTLC method for quantitation of phyllanthin, hypophyllanthin and picroside-II in marketed herbal formulation (Valiliv capsules)

Safeena Sheikh (1) , Subuddha Yadav (2) , Suhail Asghar (3) , Showkat Ahmad (4)
(1) Unijules Life Sciences Ltd., B - 35, 36 MIDC Area Kalmeshwar, Nagpur – 441501, Maharashtra, India, India ,
(2) Unijules Life Sciences Ltd., B - 35, 36 MIDC Area Kalmeshwar, Nagpur – 441501, Maharashtra, India, India ,
(3) Unijules Life Sciences Ltd., B - 35, 36 MIDC Area Kalmeshwar, Nagpur – 441501, Maharashtra, India, India ,
(4) Unijules Life Sciences Ltd., B - 35, 36 MIDC Area Kalmeshwar, Nagpur – 441501, Maharashtra, India, India

Abstract

A rapid and sensitive high-performance thin-layer chromatographic (HPTLC) method was developed and validated for quantitative estimation of Picroside-II, Phyllanthin and Hypophyllanthin simultaneously in marketed formulation (Valliliv capsule) containing Picrorhiza kurroa and Phyllanthus niruri. The sample (Valliliv capsule) were chromatographed on silica gel 60F254- TLC plates, using solvent system (Hexane: Ethyl acetate, 6:3 v/v) and scanned at 278nm. The linearity range for Picroside was 200-1600ng/spot with average recovery of 99.90%, Phyllanthin was 200-1600ng/spot with average recovery 100.41% and Hypophyllanthin 200-1600ng/spot with average recovery of 99.99% in formulation. The limit of detection and limit of quantification for Picroside-II, Phyllanthin and Hypophyllanthin were found to be 40ng/spot- 120ng/spot, 90-270ng/spot and 100ng/spot-300ng/spot. The developed method was successfully applied for the assay of market formulation containing Picrorhiza kurroa and Phyllanthus niruri.

Full text article

Generated from XML file

Authors

Safeena Sheikh
ard@unijules.com (Primary Contact)
Subuddha Yadav
Suhail Asghar
Showkat Ahmad
Safeena Sheikh, Subuddha Yadav, Suhail Asghar, & Showkat Ahmad. (2013). Development of validated HPTLC method for quantitation of phyllanthin, hypophyllanthin and picroside-II in marketed herbal formulation (Valiliv capsules). International Journal of Research in Pharmaceutical Sciences, 4(1), 50–57. Retrieved from https://ijrps.com/home/article/view/3547

Article Details

No Related Submission Found